Assessing and predicting functional and quality of life-related outcomes of islet and pancreatic transplantation in patients with type 1 diabetes mellitus

Assessing and predicting functional and quality of life-related outcomes of islet and pancreatic transplantation in patients with type 1 diabetes mellitus - Outcomes of islet and pancreatic transplantation

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON43807

Enrollment

Registered

2016-01-13

Start date

2016-03-16

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes transplantation

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Accepted for either islet or whole pancreas transplantation at the LUMC or post transplantation. Received either islet or whole pancreas tranplantation at the LUMC and are currently follow up by mixec meal tolerance test

Exclusion criteria

Exclusion criteria: -Severe cognitive or psychiatric impairment -Unable to adequately understand the Dutch language

Design outcomes

Primary

Measure	Time frame
The study endpoint for the first objective is allograft function (as assessed by mixed meal test and beta score) at 1 and 5 years, together with serum beta cell damage markers	—

Secondary

Measure	Time frame
Quality of life Hypoglycemia burden	—

Countries

Netherlands

Outcome results